Yoshinori Matsumoto (Yosuke Matsumoto)

Years Active: 2019-2022
Publications (10 Years): 6

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Katayama, Takayuki Katsuyama, Kenta Shidahara, Shoichi Nawachi, Yosuke Asano, Keiji Ohashi, Yoshia Miyawaki, Eri Katsuyama, Mariko Narazaki, Yoshinori Matsumoto, Ken-Ei Sada, Jun Wada
A case of recurrent IgG4-related disease successfully treated with belimumab after remission of systemic lupus erythematosus. Rheumatology (Oxford, England) 61 (10) (2022)
Hiroshi Ueno, Atsumi Shimada, Shunsuke Suemitsu, Shinji Murakami, Naoya Kitamura, Kenta Wani, Yu Takahashi, Yoshinori Matsumoto, Motoi Okamoto, Takeshi Ishihara
Increased anxiety-related behavior in mice following β-citronellol inhalation. The Libyan journal of medicine 15 (1) (2021)
Hiroshi Ueno, Shunsuke Suemitsu, Shinji Murakami, Naoya Kitamura, Kenta Wani, Yu Takahashi, Yoshinori Matsumoto, Motoi Okamoto, Takeshi Ishihara
Effects of haloperidol inhalation on MK-801- and memantine-induced locomotion in mice. The Libyan journal of medicine 15 (1) (2021)
Fang He, Yoshinori Matsumoto
Basic and clinical associations between bone and cancer. Immunological medicine 43 (3) (2020)
Yoshinori Matsumoto, Robert Rottapel
Bone dynamics and inflammation: lessons from rare diseases. Immunological medicine 43 (2) (2020)
Yuriko Yamamura, Yoshinori Matsumoto, Yosuke Asano, Yu Katayama, Keigo Hayashi, Keiji Ohashi, Michiko Morishita, Haruki Watanabe, Mariko Takano-Narazaki, Ken-Ei Sada, Jun Wada
Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib. Rheumatology advances in practice 4 (1) (2019)

Yoshinori Matsumoto.css-eqlu8i{font-size:small;padding-left:4px;} (Yosuke Matsumoto)